MetLife Investment Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$567K	Sell	25,091 -320	-1%	-$7.11K	﹤0.01%	1689
2025 Q4	$658K	Sell	25,411 -2,136	-8%	-$50.8K	﹤0.01%	1664
2025 Q3	$710K	Hold	27,547	–	–	﹤0.01%	1644
2025 Q2	$658K	Hold	27,547	–	–	﹤0.01%	1545
2025 Q1	$685K	Sell	27,547 -336	-1%	-$8.04K	﹤0.01%	1549
2024 Q4	$525K	Buy	27,883 +1,471	+6%	+$25.8K	﹤0.01%	1771
2024 Q3	$398K	Hold	26,412	–	–	﹤0.01%	1904
2024 Q2	$756K	Buy	26,412 +2,422	+10%	+$68.9K	﹤0.01%	1504
2024 Q1	$701K	Hold	23,990	–	–	﹤0.01%	1501
2023 Q4	$809K	Hold	23,990	–	–	0.01%	1422
2023 Q3	$736K	Hold	23,990	–	–	0.01%	1398
2023 Q2	$961K	Buy	23,990 +319	+1%	+$13.2K	0.01%	1289
2023 Q1	$966K	Hold	23,671	–	–	0.01%	1235
2022 Q4	$914K	Hold	23,671	–	–	0.01%	1265
2022 Q3	$1.26M	Hold	23,671	–	–	0.01%	1080
2022 Q2	$1.38M	Hold	23,671	–	–	0.01%	1055
2022 Q1	$1.81M	Buy	23,671 +8,425	+55%	+$562K	0.01%	1040
2021 Q4	$917K	Hold	15,246	–	–	0.01%	1165
2021 Q3	$854K	Sell	15,246 -1,510	-9%	-$87K	0.01%	1207
2021 Q2	$1.02M	Hold	16,756	–	–	0.01%	1151
2021 Q1	$1.17M	Sell	16,756 -1,751	-9%	-$125K	0.01%	1084
2020 Q4	$1.11M	Hold	18,507	–	–	0.01%	1083
2020 Q3	$1.11M	Hold	18,507	–	–	0.01%	976
2020 Q2	$971K	Hold	18,507	–	–	0.01%	1051
2020 Q1	$621K	Hold	18,507	–	–	0.01%	1103
2019 Q4	$838K	Hold	18,507	–	–	0.01%	1183
2019 Q3	$705K	Hold	18,507	–	–	0.01%	1238
2019 Q2	$805K	Hold	18,507	–	–	0.01%	1218
2019 Q1	$704K	Hold	18,507	–	–	0.01%	1245
2018 Q4	$796K	Hold	18,507	–	–	0.01%	1117
2018 Q3	$910K	Hold	18,507	–	–	0.01%	1176
2018 Q2	$593K	Hold	18,507	–	–	0.01%	1306
2018 Q1	$576K	Hold	18,507	–	–	0.01%	1290
2017 Q4	$845K	Buy	+18,507	New	+$733K	0.01%	1103